Evidence map›Paper›PMID 38329365›Full record

ArticleMicrobiology spectrum2024

Antimicrobial and anti-biofilm activity of a thiazolidinone derivative against

Rui Zhao, Bingyu Du, Yue Luo, Fen Xue, Huanhuan Wang, Di Qu, Shiqing Han, Simon Heilbronner, Yanfeng Zhao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Rui Zhao *Laboratory Medicine Center, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Bingyu Du *Laboratory Medicine Center, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.ORCID 0009-0009-8703-5591
Yue LuoCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Fen XueLaboratory Medicine Center, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Huanhuan WangDepartment of Microbial Genetics, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.
Di QuKey Laboratory of Medical Molecular Virology (MOE/NHC/CAMS) School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
Shiqing HanCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Simon HeilbronnerDepartment of Infection Biology, Interfaculty Institute of Microbiology and Infection Medicine, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-6774-2311
Yanfeng ZhaoLaboratory Medicine Center, The Second Affiliated Hospital, Nanjing Medical University, Nanjing, China.ORCID 0000-0001-6475-6171
Second Affiliated Hospital of Nanjing Medical University · CNNanjing Tech University · CNUniversity of Tübingen · DEShanghai Medical College of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnimalsAnti-Bacterial AgentsBiofilmsChlorocebus aethiopsHumansMiceMicrobial Sensitivity TestsStaphylococcus aureusVero CellsAnti-Bacterial Agentsanti-biofilm activitybacteriocidalStaphylococcus aureusWalK

Identifiers

PMID38329365
PMCPMC10913468
OpenAlexW4391653948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.